Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;72(5):1864-1872.
doi: 10.1002/hep.31480. Epub 2020 Oct 20.

Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis

Anna Bertolini  1 , Ivo P van de Peppel  1 , Frank A J A Bodewes  1 , Han Moshage  2 , Alberto Fantin  3 , Fabio Farinati  4 , Romina Fiorotto  5 , Johan W Jonker  1 , Mario Strazzabosco  5 , Henkjan J Verkade  1 , Giulia Peserico  3
Affiliations
Review

Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis

Anna Bertolini et al. Hepatology. 2020 Nov.
No abstract available

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Percentage of hospitalized COVID‐19 patients with AST or ALT elevations on admission. The studies summarized included patients with all levels of disease severity. The size of the dots reflects the relative number of patients included in each study. The upper panels represent Chinese cohorts, whereas the lower panel represents a US cohort. The weighted averages are represented by the vertical black lines and refer to the Chinese cohorts.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. WHO . Coronavirus disease 2019 (COVID‐19) Situation Report‐133. 2020. https://www.who.int/docs/default‐source/coronaviruse/situation‐reports/2.... Accessed June 1, 2020.
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China. JAMA 2020;323:1239‐1242. - PubMed
    1. Bangash MN, Patel J, Parekh D. COVID‐19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol 2020;5:529‐530. - PMC - PubMed
    1. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708‐1720. - PMC - PubMed
    1. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID‐19 patients: a retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int 2020. Apr 2. 10.1111/liv.14455. [Epub ahead of print] - DOI - PubMed

MeSH terms

Substances